Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$95.82M+382%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$235.36M+750%
Nuvation Bio logo
Nuvation BioNUVB
$610.24M+23.9%
Immunome logo
ImmunomeIMNM
$619.79M+80.9%

Other financials

Income statement

See full
Operating income-$6.3M-12.4%
Net income-$6.1M-13.5%
EPS (diluted)-$0.26+3.7%

Balance sheet

See full
Cash & equivalents$25.1M-15.9%
Total equity$14.2M-32.1%

Cash flow

See full
Operating cash flow-$6.5M-56.0%

Valuation

See full
Market cap$739.27M+335%

Returns & leverage

See full
Return on equity-154.4%+79.4pp
Current ratio2.3×-1.0×

Where this comes from

Reported directly by Nuvectis Pharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvectis Pharma, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvectis Pharma, Inc.'s total assets?
Nuvectis Pharma, Inc. (NVCT) reported total assets of $25.4M in Q1 2026.
How has Nuvectis Pharma, Inc.'s total assets changed year-over-year?
Nuvectis Pharma, Inc.'s total assets decreased by 15.8% year-over-year, from $30.15M to $25.4M.
What is the long-term trend for Nuvectis Pharma, Inc.'s total assets?
Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s total assets has grown at a 47.7% compound annual growth rate (CAGR), from $6.66M to $31.71M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.